Sort
64,565 grants matching “drug discovery”
Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis
$913,161Primo N Lara · University Of California At Davis · K12 · FY2019 · CA
Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis
$913,097Scott Scarneo · Eydis Bio, Inc. · R44 · FY2022 · AR
Entry and replication of positive-sense, RNA viruses
$912,922Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$912,707Nitin S Baliga · Institute For Systems Biology · R01 · FY2018 · AI
Nuclear Factor-kappaB in Ovarian Cancer
$912,704Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain
$912,586Subramaniam Ananthan · Southern Research Institute · R01 · FY2015 · DA
Phase 2 Clinical Trials Program for Experimental Therapeutics Clinical Trials Network
$912,510Alex A Adjei · Mayo Clinic Rochester · UM1 · FY2016 · CA
Aging Intervention Program
$912,434Rafael De Cabo · National Institute On Aging · ZIA · FY2025 · AG
Vascular remodeling in patients with rare genetic disorders
$912,408Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Biosynthesis, Processing And Secretion of Neuropeptides And Pituitary Hormones
$912,365Yoke P Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
The Integrative Genomics of Acute Asthma Control
$912,174Benjamin Alexander Raby · Brigham And Women'S Hospital · R01 · FY2014 · HL
Targeting SDF-1 for effective wet AMD treatment
$911,698Qiang Gong · Aptitude Medical Systems, Inc. · R44 · FY2020 · EY
Research and Development of Effective Therapies for Patients with Rare Tumors
$911,495Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
The integrated stress response in cognitive disorders
$911,165Mauro Costa-Mattioli · Baylor College Of Medicine · R01 · FY2021 · NS
NRF Transcription Factors in Environmental Stress and Disease Intervention
$911,114Donna D Zhang · University Of Arizona · R35 · FY2022 · ES
AdaptiSPECT-C: A Next-Generation, Adaptive Brain-Imaging SPECT System for Drug Discovery and Clinical Imaging
$911,011Michael A King · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · EB
Biological annotation of TCGA data
$910,976Gordon B. Mills · University Of Tx Md Anderson Can Ctr · U01 · FY2015 · CA
A Breath-based Medicaton Adherence Monitoring System for HIVAIDS Therapies
$910,967Richard J Melker · Xhale, Inc. · R44 · FY2009 · MH
Material-guided delivery and local activation of bioorthogonal prodrugs
$910,710Sangeetha Srinivasan · Tambo, Inc. · R44 · FY2020 · GM
Quantitative and highly versatile chromatin accessibility platform
$910,411Michael-Christopher Keogh · Epicypher, Inc. · R44 · FY2020 · HG
High-throughput genetic & small-molecule screening for therapeutic modifiers
$910,336Kevin P. Campbell · University Of Iowa · RC2 · FY2010 · NS
Next-generation 5-nitroimidazoles against giardiasis
$910,179Lars Eckmann · University Of California, San Diego · U01 · FY2009 · AI
Physical Mechanisms of Cell State Transitions: Size Homeostasis in Budding Yeast
$910,000Catherine A Royer · Rensselaer Polytechnic Institute · · FY2018 · MPS
SBIR Phase II: A novel multicolor cell line engineering platform that enables high-throughput microscopy-based screening of living cells for drug discovery
$909,999Mary J Ludlam · Cairn Biosciences · · FY2016 · TIP
Identification and characterization of novel drugs that target the Influenza
$909,915Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2016 · AI